Sign Up Today and Learn More About CapsoVision Stock
Invest in or calculate the value of your shares in CapsoVision or other pre-IPO companies through EquityZen's platform.

CapsoVision Stock (CAVI)
CapsoVision is a global medical device innovator that specializes in the fields of capsule endoscopy, medical device, and healthcare.
About CapsoVision Stock
Founded
2005
Headquarters
Saratoga, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
CapsoVision is a medical device company that provides a 360° panoramic view of the small bowel, providing you with a direct view of the mucosa instead of down the tunnel allowing visibility of more pathology. It features a cloud-based platform that allows its users to extract data from the CapsoCam Plus capsule without the need to process post-ingestion. It was founded in 2005 and headquartered in Saratoga, California.
CapsoVision Press Mentions
Stay in the know about the latest news on CapsoVision
Smart Pills Market Global Forecast Report to 2030, with Tariff & Regulatory Analysis
globenewswire • Apr 08, 2025
Smart Pills Market worth US$1.30 billion by 2030 with 11.2% CAGR | MarketsandMarkets™
prnewswire • Mar 27, 2025
Smart Pills Market worth US$1.30 billion by 2030 with 11.2% CAGR | MarketsandMarkets™
prnewswire • Mar 27, 2025
Smart Pills Drug Delivery Market Expected to Achieve a Strong 10.35% CAGR, to Reach USD 8.7 Billion by 2035
einpresswire • Mar 18, 2025
Intelligent in vivo Capsule Device with Electrodes
patents • Feb 08, 2025
CapsoVision Management
Leadership team at CapsoVision
President
Kang Huai Wang
Associate Manager Channel Sales
Elina Filipova

Join now and verify your accreditation status to gain access to:
- CapsoVision Current Valuation
- CapsoVision Stock Price
- CapsoVision Management
- Available deals in CapsoVision and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- CapsoVision Cap Table and Funding History by Share Class and Liquidity Preferences
- CapsoVision Revenue and Financials
- CapsoVision Highlights
- CapsoVision Business Model
- CapsoVision Risk Factors
- CapsoVision Research Report from SACRA Research
Trading CapsoVision Stock
How to invest in CapsoVision stock?
Accredited investors can buy pre-IPO stock in companies like CapsoVision through EquityZen funds. These investments are made available by existing CapsoVision shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CapsoVision stock?
Shareholders can sell their CapsoVision stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."